Novartis (NVS) agreed to acquire AveXis (AVXS) for $8.7 billion on Monday. 

"This is squarely in the crosshairs of Biogen (BIIB) which has that great deal with Ionis (IONS) ," said TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.

Want exclusive investing insight from Jim Cramer? Get 24/7 access to Jim's charitable trust portfolio with a free trial to Action Alerts PLUS!

Watch all of Jim Cramer's full NYSE live shows right here:

More from Video

A Guide to Investing in the Fast-Emerging Cannabis Industry

A Guide to Investing in the Fast-Emerging Cannabis Industry

Canadian Pot Legalization Could Be A Fresh Tailwind for Cannabis Stocks

Canadian Pot Legalization Could Be A Fresh Tailwind for Cannabis Stocks

Striking Options: Earnings, Gold, & Nasdaq

Striking Options: Earnings, Gold, & Nasdaq

This Market is Comparable to Getting Into a 'Fist Fight'

This Market is Comparable to Getting Into a 'Fist Fight'

3 Things Investors Can Do to Stay Strategic When the Market's Volatile

3 Things Investors Can Do to Stay Strategic When the Market's Volatile